Notes - Segment Information, Etc.

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7252445

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
8,735,000,000 JPY
75,299,000,000 JPY
860,000,000 JPY
88,330,000,000 JPY
3,435,000,000 JPY
3,022,000,000 JPY
809,000,000 JPY
63,348,000,000 JPY
75,579,000,000 JPY
8,399,000,000 JPY
Transactions with other segments
2,660,000,000 JPY
JPY
207,000,000 JPY
5,418,000,000 JPY
2,550,000,000 JPY
1,893,000,000 JPY
173,000,000 JPY
JPY
4,179,000,000 JPY
2,112,000,000 JPY
Other items
Depreciation
610,000,000 JPY
4,129,000,000 JPY
33,000,000 JPY
4,796,000,000 JPY
23,000,000 JPY
23,000,000 JPY
21,000,000 JPY
3,905,000,000 JPY
4,404,000,000 JPY
454,000,000 JPY
Increase in property, plant and equipment and intangible assets
884,000,000 JPY
8,086,000,000 JPY
10,000,000 JPY
9,012,000,000 JPY
31,000,000 JPY
39,000,000 JPY
150,000,000 JPY
3,187,000,000 JPY
4,090,000,000 JPY
712,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.